eXoZymes (EXOZ) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
eXoZymes (EXOZ) has outperformed Instil Bio (TIL) over the past year, losing 59.0% versus a loss of 62.9%. eXoZymes is the larger company by market cap ($51.5 million vs $46.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EXOZ | TIL |
|---|---|---|
| Share price | $5.54 | $6.90 |
| Market cap | $51.55M | $46.80M |
| 1-day change | -3.15% | +0.22% |
| YTD return | -49.17% | -37.27% |
| 1-year return | -58.96% | -62.86% |
| 5-year return | — | -98.07% |
| EPS (TTM) | $-1.19 | $-4.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.40 | $21.98 |
| 52-week low | $4.35 | $5.67 |
| Distance from 52-week high | -69.89% | -68.61% |
| Average volume | 6.79K | 12.01K |
| Shares outstanding | 9.30M | 6.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
EXOZ vs TIL FAQ
Which is bigger, eXoZymes or Instil Bio?
eXoZymes (EXOZ) is larger, with a market capitalization of $51.55M compared with $46.80M for Instil Bio (TIL).
Which stock has performed better over the past year, EXOZ or TIL?
EXOZ returned -58.96% over the past 12 months, compared with -62.86% for TIL (price return, excluding dividends). Past performance does not predict future results.
Are eXoZymes and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.